NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1659641355 M.B,B.S
Verify on CMS → Mohini Bollineni, M.B,B.S
Endocrinology, Diabetes & Metabolism Physician in Temple, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 426 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
43%
generic claims · 48% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Mohini Bollineni, M.B,B.S filed 2,696 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in Temple, Texas, prescribing 43% generic.
- 3K
- Part D claims, 2023
- 43%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Mohini Bollineni, M.B,B.S's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
2,696 Top 13% higher than 87% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Mohini Bollineni, M.B,B.S practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mohini Bollineni, M.B,B.S?
Quality data not reportedPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
2,696 2% vs specialty avg
Specialty distribution in Texas
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Texas providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Mohini Bollineni, M.B,B.S appears in the CMS NPPES registry as an Endocrinology, Diabetes & Metabolism Physician provider holding M.B,B.S credentials at 1605 S 31ST, Temple, TX, 76508, with a listed phone of (254) 215-0100. NPI 1659641355 was issued on 01/11/2012.
Medicare Part D records for calendar year 2023 show 2,696 prescription claims written by this provider, covering 426 Medicare beneficiaries and totaling roughly $1.6 million in drug spend, split 48% brand-name and 43% generic by claim count.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,871 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1659641355 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | M.B,B.S |
| Gender | Female |
| NPI Issued | 01/11/2012 |
Hospital and facility affiliations
Facilities where Mohini Bollineni, M.B,B.S bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Scott And White Clinic
Temple, TX
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Mohini Bollineni, M.B,B.S. To verify Mohini Bollineni, M.B,B.S's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Mohini Bollineni, M.B,B.S - brand share 48.0%
Endocrinology, Diabetes & Metabolism Physician average
48% brand-name claims vs 43% generic, on 2,696 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
2,696
Total Claims
$1.6M
Total Drug Cost
426
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 6,645
- Total Day Supply
- 197,716
- Brand vs Generic
- 48% brand / 43% generic
- Brand Drug Cost
- $1.5M
- Generic Drug Cost
- $38K
Patient Demographics
- Average Patient Age
- 68.9 years
- Avg HCC Risk Score
- 2.16
- Gender Split
- 62% female / 38% male
- Age Distribution
- <65: 104, 65-74: 195, 75-84: 109, 85+: 18
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Mohini Bollineni, M.B,B.S prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
442 claims
- Ozempic
Ozempic
190 claims
- Jardiance 150
Jardiance
150 claims
- Metformin Hcl 144
Metformin Hcl
144 claims
- Atorvastatin Calcium 130
Atorvastatin Calcium
130 claims
- Alendronate Sodium 84
Alendronate Sodium
84 claims
- Humalog Kwikpen U-… 71
Humalog Kwikpen U-100
71 claims
- Novolog Flexpen 70
Novolog Flexpen
70 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 442 |
| Ozempic Semaglutide | 190 |
| Jardiance Empagliflozin | 150 |
| Metformin Hcl | 144 |
| Atorvastatin Calcium | 130 |
| Alendronate Sodium | 84 |
| Humalog Kwikpen U-100 Insulin Lispro | 71 |
| Novolog Flexpen Insulin Aspart | 70 |
| Trulicity Dulaglutide | 62 |
| Hydrocortisone | 58 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in TX →
All providers in Texas →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Mohini Bollineni, M.B,B.S fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Mohini Bollineni, M.B,B.S's 2,696 claims are above the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Bollineni.
Dr. Nicola Abate
MD
Baytown, TX
Dr. Jessica Abramowitz
MD
Dallas, TX
Dr. Layla Abushamat
M.D., M.P.H.
Houston, TX
Dr. Luis Acosta
MD
Houston, TX
Dr. Stefanie Addington
M.D.
Frisco, TX
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Texas
Frequently Asked Questions
What is Mohini Bollineni, M.B,B.S's specialty? ▼
Mohini Bollineni, M.B,B.S specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Temple, Texas. Credentials: M.B,B.S.
How much does Mohini Bollineni, M.B,B.S prescribe under Medicare Part D? ▼
In 2023, Mohini Bollineni, M.B,B.S wrote 2,696 Medicare Part D claims totaling $1.6M in drug costs for 426 beneficiaries.
Where is Mohini Bollineni, M.B,B.S located? ▼
Mohini Bollineni, M.B,B.S is located at 1605 S 31ST, Temple, TX, 76508. Phone: (254) 215-0100.
What is Mohini Bollineni, M.B,B.S's NPI number? ▼
Mohini Bollineni, M.B,B.S's National Provider Identifier (NPI) is 1659641355, issued on 01/11/2012.
Does Mohini Bollineni, M.B,B.S prescribe more brand-name or generic drugs? ▼
Mohini Bollineni, M.B,B.S's prescribing is 48% brand-name and 43% generic drugs by claim count, with $1.5M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Mohini Bollineni, M.B,B.S prescribe most often? ▼
Based on 2023 Medicare Part D data, Mohini Bollineni, M.B,B.S's most frequently prescribed drugs include Levothyroxine Sodium, Ozempic, Jardiance. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mohini Bollineni, M.B,B.S accept Medicare? ▼
Mohini Bollineni, M.B,B.S appears in CMS Medicare data with 2,696 Part D claims and 426 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mohini Bollineni, M.B,B.S's credentials? ▼
Mohini Bollineni, M.B,B.S's NPI is 1659641355 with credentials M.B,B.S. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.